Ανασκοπήσεις – Κλινικές περιπτώσεις
Therapeutic Strategies for the Treatment of Severe Cushing’s Syndrome.
Alexandraki KI, Grossman AB.
Drugs. 2016 Feb 1. [Epub ahead of print]
Appendiceal neuroendocrine neoplasms: diagnosis and management.
Alexandraki KI, Kaltsas GA, Grozinsky-Glasberg S, Chatzellis E, Grossman AB.
Endocr Relat Cancer. 2016 Jan;23(1):R27-41. doi: 10.1530/ERC-15-0310. Epub 2015 Oct 19. Review.
Metastatic pheochromocytoma and paraganglioma.
Angelousi A, Kassi E, Zografos G, Kaltsas G.
Eur J Clin Invest. 2015 Sep;45(9):986-97. doi: 10.1111/eci.12495.
Kaltsas G.
In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Apr 12.
Current Issues in the Diagnosis and Management of Adrenocortical Carcinomas.
Kassi E, Kaltsas G, Zografos G, Chrousos G.
In: De Groot LJ, Beck-Peccoz P, Chrousos G, Dungan K, Grossman A, Hershman JM, Koch C, McLachlan R, New M, Rebar R, Singer F, Vinik A, Weickert MO, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2009 Oct 10.
Surgical treatment of potentially primary malignant adrenal tumors: an unresolved issue.
Zografos GN, Perysinakis I, Kyrodimou E, Kassi E, Kaltsas G.
Hormones (Athens). 2015 Jan-Mar;14(1):47-58. Review.
PMID:
Clinical Syndromes Related to Gastrointestinal Neuroendocrine Neoplasms.
Boutzios G, Kaltsas G.
Front Horm Res. 2015;44:40-57. doi: 10.1159/000382053. Epub 2015 Aug 14.
Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.
Kaltsas G, Grozinsky-Glasberg S, Alexandraki KI, Thomas D, Tsolakis AV, Gross D, Grossman AB.
Clin Endocrinol (Oxf). 2014 Aug;81(2):157-68. doi: 10.1111/cen.12476. Epub 2014 May 26. Review.
Koumarianou A, Chatzellis E, Boutzios G, Tsavaris N, Kaltsas G.
Endokrynol Pol. 2013;64(1):60-72. Review.
Boutzios G, Griniatsos J, Dimitriou N, Zilos A, Antoniou S, Felekouras E, Kaltsas G.
Hormones (Athens). 2013 Oct-Dec;12(4):517-21. Review.
Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
Kanakis G, Kaltsas G.
Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):791-802. doi: 10.1016/j.bpg.2012.12.006. Review.
Current status and controversies in adrenal incidentalomas.
Kaltsas G, Chrisoulidou A, Piaditis G, Kassi E, Chrousos G.
Trends Endocrinol Metab. 2012 Dec;23(12):602-9. doi: 10.1016/j.tem.2012.09.001. Epub 2012 Oct 5.
Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.
Alexandraki KI, Kaltsas G.
Endocrine. 2012 Feb;41(1):40-52. doi: 10.1007/s12020-011-9562-2. Epub 2011 Nov 29. Review.
Letter from Springer (PDF) ***
The clinical significance of adrenal incidentalomas.
Androulakis II, Kaltsas G, Piaditis G, Grossman AB.
Eur J Clin Invest. 2011 May;41(5):552-60. doi: 10.1111/j.1365-2362.2010.02436.x. Epub 2011 Jan 7. Review.
Alexandraki KI, Grossman AB.
Rev Endocr Metab Disord. 2010 Jun;11(2):117-26. doi: 10.1007/s11154-010-9139-z. Review.
PMID: